REBYOTA

Manufacturer:

FERRING PHARMACEUTICALS, INC.

Name:

REBYOTA

HCPCS Code Descriptor:

Fecal microbiota, live - jslm, 1 ml

Category:

J Code

HCPCS:

J1440

NDC(s):

55566-9800-02

Primary Type:

Fecal

Generic Status:

Single-Source

Route of Administration:

Rectal

About:

REBYOTA is a Fecal drug manufactured by FERRING PHARMACEUTICALS, INC. and administered via the Rectal route of administration. The J Code: J1440 is aligned to the drug REBYOTA.

Rebyota is a gastrointestinal agent that works by using healthy bacteria from stool. These healthy bacteria are used to treat CDI. Rebyota is the first microbiome-based treatment approved by the U.S. Food and Drug Administration (FDA) to prevent recurrence of CDI. This is used to help prevent a certain type of infection. Rebyota is aligned to the HPCS code J1440 and is not a generic medication that is manufactured by Ferring Pharmaceuticals. Patient assistance programs for this medication can be found through Rebyota’s website.